Total Synthesis of (+)-Aspercyclide A and Analogues

Projektinformationen

TSASPERA

ID Finanzhilfevereinbarung: 253556

Abgeschlossenes Projekt

Startdatum 13 März 2011

Enddatum 12 März 2013

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 180 103,20

EU-Beitrag € 180 103,20

Koordiniert durch

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom

Ziel

The incidence of allergic disease, from hay fever to asthma and anaphylactic shock, is increasing world-wide, nowhere more than in the UK where it has risen three-fold in 20 years and is now the highest in the world. Allergies including asthma afflict 40% of the UK population and bronchial asthma currently affects 5.2 million. The yearly cost to the UK National Health System in primary care alone exceeds €1,200M, and the loss of 18 million working days costs a further €1,400M. The quality of life for many sufferers is severely impaired. Historical medications (e.g. steroids) simply alleviate the side effects of allergy and are associated with debilitating side-effects. Recently, the humanised monoclonal antibody Zolair® has been approved for treatment of chronic asthma; this acts by inhibiting a specific protein-protein interaction (PPI) common to all allergic responses and is very effective but it is highly expensive and is administered via injection in a regime that is unsustainable for many body sizes. This research is aimed at the development of new a series of small, drug-like molecules based on a natural product lead as potential anti-asthma therapeutic leads with the same mode of action as Zolair®. The molecules will be prepared by synthesis and tested for activity in Enzyme-Linked Immunosorbent Assay (ELISA) and Surface Plasmon Resonance (SPR) assays and promising candidates subjected to co-crystallisation studies with their protein partner.

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › pneumology › asthma
• natural sciences › biological sciences › biochemistry › biomolecules › proteins › proteomics
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• agricultural sciences › agriculture, forestry, and fisheries › agriculture › industrial crops › fodder
• medical and health sciences › clinical medicine › allergology

Programm/Programme

• FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Thema/Themen

• FP7-PEOPLE-2009-IEF - Marie Curie Action: "Intra-European Fellowships for Career Development"

Aufforderung zur Vorschlagseinreichung

FP7-PEOPLE-2009-IEF
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

MC-IEF - Intra-European Fellowships (IEF)

Koordinator

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

Kontakt Verwaltung

Brooke Alasya (Ms.)

• EU-Beitrag: € 180 103,20
• Adresse: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD ; SW7 2AZ LONDON ; Vereinigtes Königreich
• Region: London › Inner London — West › Westminster
• Aktivitätstyp: Higher or Secondary Education Establishments
• Gesamtkosten: Keine Daten